Showing results (131-140 of 193) with videos related to

Sort By:
Pageof 20
BMC Cancer|December 31, 2018
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysisYu-Jing Liang, Lin-Quan Tang, Xue-Song Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2026
Long-Term Outcomes of Reduced-Dose Radiotherapy in Patients with Epstein-Barr Virus DNA-Selected Stage III Nasopharyngeal Carcinoma: A 5-Year Follow-Up Secondary Analysis of a Phase II TrialYu-Xi Xiao, Jin-Hao Yang, Xue-Song Sun, et al.
BMC Cancer|October 9, 2016
With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control studyLi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
BMJ Oncology|August 5, 2025
Real-world experience on efficacy and safety of different adjuvant chemotherapy regimens in locoregionally advanced nasopharyngeal carcinomaJie Chen, Hui Cheng, Yi-Fu Li, et al.
European Journal of Radiology|September 20, 2025
Potential values of uEXPLORER total-body PET/CT in nasopharyngeal carcinoma: dynamic imaging and kinetic parametersYing-Ying Hu, Zhen-Chong Yang, Li-Ping Liang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2023
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinomaYu-Chen, Mei-Juan Luo, Rong-Ping Liu, et al.
Cancer Research and Treatment|March 28, 2019
Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort StudyXue-Song Sun, Di-Han Liu, Sai-Lan Liu, et al.
Cancer Communications (London, England)|March 31, 2019
The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective studySai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
Plos One|April 16, 2015
Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy eraLin Quan Tang, Dong Peng Hu, Qiu Yan Chen, et al.
Oncotarget|December 31, 2015
Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapyLu Zhang, Lin-Quan Tang, Qiu-Yan Chen, et al.
Pageof 20